Trademarkia Logo

Canada

C$
Trademark Search in Canada
STYLIZED LINES DESIGN

View On IC.GC.CA

STYLIZED LINES DESIGN
REGISTERED

on 2 Aug 2024

Last Applicant/ Owned by

MERCK SHARP & DOHME B.V.

Waarderweg 39NL-2031 BN Haarlem

NL

Serial Number

2183843 filed on 31st Mar 2022

Registration Number

TMA1248107 registered on 2th Aug 2024

Registration expiry Date

31st Mar 2032

Correspondent Address

BORDEN LADNER GERVAIS LLP

Bay Adelaide Centre, East Tower22 Adelaide St. WestTORONTO

ONTARIO

CA

M5H4E3

STYLIZED LINES DESIGN

Trademark usage description

pharmaceutical preparations and substances for the prevention and treatment of bone, cardiovascular, hematological, hepatological, immunological, gast Read More

Vienna Information

26 . 11 . 2

Two lines or bandsDeux lignes ou bandes

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 11 . 21

Set of lines evoking speed or propulsionEnsemble de lignes évoquant la vitesse ou la propulsion

26 . 13 . 25

Other geometrical figures, indefinable designs -- Note: Including scratch marks.Autres figures géométriques, dessins indéfinissables -- Note: Y compris les marques de griffes.

2 . 9 . 25

Other parts of the human body -- Notes: (a) Including human or animal sperm. (b) Not including heads, which will be placed in the appropriate sections of divisions 2.1, 2.3, 2.5 or 2.7.Autres parties du corps humain -- Notes: Y compris le sperme humain ou animal. (b) Non compris les têtes qui seront rangées dans les sections appropriées des divisions 2.1, 2.3, 2.5 ou 2.7.

2 . 9 . 26

BrainsCerveaux

29 . 1 . 5

VioletViolet

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 2

Yellow, goldJaune, or

29 . 1 . 6

White, grey, silverBlanc, gris, argent

29 . 1 . 8

BlackNoir

26 . 13 . 1

Stains, spots, blots, brush strokesTaches, coups de pinceau

Classification Information

Class [005]
Pharmaceutical preparations and substances for the prevention and treatment of bone, cardiovascular, hematological, hepatological, immunological, gastrointestinal, musculoskeletal, nephrological, oncological, ophthalmic, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; Pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, namely bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, psoriasis, eczema, and dermatitis; Pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the endocrine system, namely, glucagonoma, growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations and substances for the prevention and treatment of genitourinary diseases and disorders, namely, infertility, sexually transmitted diseases, inflammatory pelvic diseases; Pharmaceutical preparations and substances for the prevention and treatment of gynecological diseases and disorders, namely amenorrhoea, dysmenorrheal and diseases and disorders relating to sexual reproduction and fertility; Pharmaceutical preparations and substances for the prevention and treatment of metabolic diseases and disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, arthritis, obesity and hypothyroidism; Pharmaceutical preparations and substances for the prevention and treatment of neurological diseases and disorders, namely, schizophrenia pain, neuropathic pain; Pharmaceutical preparations and substances for the prevention and treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, psychoses and bipolar disorders; Pharmaceutical preparations and substances for the prevention and treatment of Respiratory Syncytial Virus (RSV); Pharmaceutical preparations substances for the prevention and treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, namely, dermatitis, skin pigmentation diseases, psoriasis, acne, rosacea, ichthyosis, urticaria and urinary incontinence; Pharmaceutical preparations, namely, anti-bacterials, antibiotics, anti-fungals, anti-infectives, anti-inflammatories, anti-parasitics, and antivirals; Human vaccine preparations; Inhaled pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders

Classification kind code

11

Mark Details

Serial Number

2183843

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 7th Sept 2023		Agent Changed
Submitted for opposition 22
on 18th Aug 2023		Search Recorded
Submitted for opposition 20
on 18th Aug 2023		Examiner's First Report
Submitted for opposition 223
on 18th Aug 2023		Total Provisional Refusal
Submitted for opposition 256
on 6th Mar 2023		Notification of Possible Opposition Sent
Submitted for opposition 257
on 5th May 2022		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 5th May 2022		Created
Submitted for opposition 31
on 5th May 2022		Formalized
Submitted for opposition 30
on 31st Mar 2022		Filed
Submitted for opposition 228
on 31st Mar 2022		International Registration